India’s chemical industry plays an important role in sectors ranging from pharmaceuticals and food processing to water treatment, mining and oil exploration. Within this broad industry, inorganic chemicals are often critical inputs used in manufacturing and industrial processes.
The Shanti Inorganics IPO gives investors an opportunity to participate in a company that manufactures and supplies sulphur-based inorganic chemicals.
The company is among India’s larger producers of bisulphite chemicals, with an installed capacity of approximately 18,800 metric tonnes per annum (MTPA).
Its products are used across several industries, including food, pharmaceuticals, water treatment, oil drilling, chemicals and mining.
The company has also reported healthy financial growth, with revenue increasing by 25% and profit after tax increasing by 28% in FY26 compared with FY25.
However, around 30% of its revenue comes from exports, which exposes the company to international market conditions, currency movements and changes in overseas demand.
On this page
Shanti Inorganics IPO: Key Takeaways
Before looking at the business and financials in detail, here are the key points investors should know:
- Shanti Inorganics manufactures sulphur-based inorganic chemicals.
- It is among India’s largest producers of bisulphite products.
- Installed capacity stands at approximately 18,800 MTPA.
- Its products serve food, pharmaceutical, water treatment, mining, chemical and oil-drilling industries.
- FY26 revenue increased by approximately 25%.
- FY26 PAT increased by approximately 28%.
- Around 30% of revenue comes from exports.
- The IPO size is approximately ₹47 crore.
- The price band is ₹79–₹83 per share.
- The lot size is 1,600 shares.
- The minimum investment mentioned for the IPO is ₹2,65,600.
- The IPO is scheduled to open from 31 August to 2 September 2026.
What Does Shanti Inorganics Do?
Shanti Inorganics manufactures and supplies sulphur-based inorganic chemicals that are used as industrial inputs across multiple sectors.
Its product portfolio includes chemicals such as:
- Ammonium bisulphite
- Sodium bisulphite
- Sodium metabisulphite
- Sodium sulphite
These chemicals can serve different purposes depending on the industry and application.
They may be used as preservatives, reducing agents and process chemicals.
This gives the company exposure to multiple end-use industries rather than depending entirely on one customer segment.
Where Are Shanti Inorganics’ Products Used?
The company’s chemicals are used across a diverse set of industries.
Food Industry
Sulphite-based chemicals can be used in food-related applications, including preservation and processing.
Pharmaceutical Industry
These chemicals can serve as process inputs in pharmaceutical manufacturing.
Water Treatment
Sulphur-based chemicals are also used in water-treatment applications, where chemical treatment plays an important role in industrial and municipal processes.
Oil Drilling
Certain products are used as process chemicals in oil and drilling-related applications.
Mining and Chemicals
The company’s products also find applications in mining and other chemical manufacturing processes.
The diversified end-user base can help reduce dependence on a single industry, although demand can still fluctuate with industrial and economic activity.
Why Is Bisulphite Manufacturing Important?
Shanti Inorganics has a significant presence in the bisulphite market.
The company’s installed capacity is approximately 18,800 MTPA, placing it among India’s larger producers.
Specialised chemical manufacturing can benefit from customer relationships, product quality, technical know-how and manufacturing capabilities.
However, the chemical industry can also be cyclical.
Changes in raw-material prices, competition, demand and export markets can affect profitability.
Shanti Inorganics Financial Performance
The company has reported strong financial growth.
Revenue increased by approximately 25% in FY26 compared with FY25.
Profit after tax increased by approximately 28% during the same period.
This indicates that profit grew slightly faster than revenue, suggesting that profitability remained healthy during the period.
Financial Snapshot
| Particulars | FY26 Performance |
| Revenue Growth | 25% |
| PAT Growth | 28% |
| H1FY26 Total Income | ₹16.10 crore |
| H1FY26 Profit | ₹2.5 crore |
| H1FY26 CFO | ₹10 crore |
| FY26 CFO | ₹6 crore |
The operating cash flow figures also require attention.
The company generated approximately ₹10 crore of CFO during H1FY26, while the full-year FY26 CFO was approximately ₹6 crore based on the figures provided.
This indicates that cash generation can vary significantly between reporting periods and should be evaluated alongside working-capital movements.
Why Is Cash Flow Important?
Profit and cash flow are not the same thing.
A company can report accounting profit while cash remains tied up in receivables, inventory or other working-capital requirements.
For a chemical manufacturer, cash flow can be influenced by:
- Raw-material purchases
- Inventory levels
- Customer payment cycles
- Export receivables
- Tax payments
- Capital expenditure
Therefore, investors should look beyond PAT and assess whether the company’s earnings are consistently converting into cash.
A financial advisory company in India can help investors evaluate these factors along with valuation, business risks and portfolio suitability before making an IPO investment decision.
What Are the Key Risks in Shanti Inorganics IPO?
Export Dependence
The most clearly highlighted risk is the company’s exposure to international markets.
Approximately 30% of revenue comes from exports.
This gives Shanti Inorganics access to overseas markets but also exposes it to several external factors.
These can include:
- International demand
- Currency fluctuations
- Global economic conditions
- Trade restrictions
- Changes in regulations
- Geopolitical developments
- Overseas competition
If demand from international customers weakens, the company’s overall revenue and profitability could be affected.
Currency Risk
Since a meaningful portion of revenue comes from exports, fluctuations in foreign exchange rates can affect the value of export earnings when converted into Indian rupees.
A favourable currency movement can support reported revenue, while an unfavourable movement can have the opposite effect.
Chemical Industry Competition
Chemical manufacturing is a competitive industry.
Changes in raw-material prices, new competitors, manufacturing capacity and pricing pressure can affect margins.
Investors should therefore track whether the company can maintain its profitability as it expands.
Working Capital and Cash Conversion
The difference between the company’s profit and operating cash flow in different periods highlights the importance of monitoring cash conversion.
A growing business can require additional working capital as sales increase.
If receivables or inventory rise faster than revenue, more cash can become tied up in operations.
Shanti Inorganics IPO Issue Details
The total issue size is approximately ₹47 crore.
Invest Smarter.
Grow Confidently.
Your AI-powered SEBI-registered investment advisor — with research you can trust and insights that grow with you.
Download inXits Free
The IPO is priced in the range of ₹79 to ₹83 per share.
IPO Snapshot
| Particular | Details |
| IPO Opening Date | 31 August 2026 |
| IPO Closing Date | 2 September 2026 |
| Allotment Date | 3 September 2026 |
| Expected Listing Date | 7 September 2026 |
| Price Band | ₹79 – ₹83 per share |
| Total Issue Size | ₹47 crore |
| Lot Size | 1,600 shares |
| Minimum Investment | ₹2,65,600 |
At the upper price band of ₹83, one lot of 1,600 shares would have a value of ₹1,32,800.
The stated minimum investment of ₹2,65,600 therefore corresponds to an application for two lots.
Investors should verify the final lot and application requirements in the official IPO documents before applying.
What Is the GMP of Shanti Inorganics IPO?
The Grey Market Premium (GMP) is an unofficial market indicator that can sometimes reflect market expectations before listing.
Based on the figure provided, the current GMP is approximately 30.12%, equivalent to around ₹40,000 on the stated minimum application amount.
However, investors should be careful when interpreting GMP.
GMP is not an official exchange price, is not guaranteed, and can change rapidly before listing.
It should therefore not be treated as a prediction of the actual listing price or guaranteed return.
The company’s fundamentals, valuation, financial performance and risks are more important when evaluating an IPO for long-term investment.
How Should Investors Evaluate Shanti Inorganics IPO?
Shanti Inorganics operates in an important segment of the chemical industry and has established manufacturing capacity in sulphur-based inorganic chemicals.
The positive factors include:
- Strong revenue growth
- Strong PAT growth
- Established product portfolio
- 18,800 MTPA production capacity
- Diversified end-use industries
- Export presence
- Exposure to food, pharma, water treatment and industrial sectors
However, investors should also consider:
- 30% export contribution
- International market risks
- Currency fluctuations
- Chemical industry competition
- Cash-flow variability
- Working-capital requirements
- IPO valuation
The key question is not simply whether the company is growing.
Investors should also ask whether the growth is sustainable, whether margins can remain healthy and whether profits consistently convert into cash.
Is Shanti Inorganics a Diversified Chemical Company?
To some extent, yes.
The company does not depend on a single end-use industry.
Its products are used across food, pharmaceuticals, water treatment, oil drilling, mining and chemical applications.
This diversification can provide some protection if demand in one industry slows.
However, diversification does not eliminate business risk.
The company remains exposed to raw-material costs, competition, industrial demand and international markets.
What Should Investors Watch After the IPO?
Investors following Shanti Inorganics after listing should monitor several indicators.
Revenue Growth
Continued growth would indicate sustained demand for its products.
Profit Margins
Revenue growth is useful only if profitability remains healthy.
Operating Cash Flow
Consistent positive operating cash flow would provide greater confidence in the quality of reported earnings.
Export Contribution
Since around 30% of revenue comes from exports, changes in overseas demand should be monitored.
Capacity Utilisation
As the company has significant installed capacity, utilisation levels can provide insight into how efficiently its manufacturing assets are being used.
Working Capital
Receivables and inventory should be monitored because they directly influence cash generation.
Conclusion
The Shanti Inorganics IPO offers investors exposure to an established sulphur-based inorganic chemicals manufacturer serving several industries.
The company has reported encouraging growth, with FY26 revenue increasing by approximately 25% and PAT rising by around 28%.
Its 18,800 MTPA capacity and presence across industries such as food, pharmaceuticals, water treatment, mining and oil drilling provide a diversified customer application base.
However, approximately 30% of revenue comes from exports, making international markets an important risk factor.
Cash-flow performance should also be monitored closely because the company’s reported CFO has varied significantly between reporting periods.
The IPO is priced at ₹79–₹83 per share, with a total issue size of approximately ₹47 crore. The minimum application mentioned is ₹2,65,600 based on two lots of 1,600 shares each.
While the reported GMP of around 30.12% may attract short-term investor attention, GMP is unofficial and can change before listing. It should not be considered a guarantee of listing gains or future returns.
Ultimately, investors should evaluate the company’s financial performance, cash generation, export exposure, industry outlook and valuation before making an investment decision.
Frequently Asked Questions
What is the Shanti Inorganics IPO?
The Shanti Inorganics IPO is the public offering of a company that manufactures and supplies sulphur-based inorganic chemicals for industries including food, pharmaceuticals, water treatment, mining and chemicals.
What does Shanti Inorganics manufacture?
The company manufactures products such as ammonium bisulphite, sodium bisulphite, sodium metabisulphite and sodium sulphite.
What is Shanti Inorganics’ production capacity?
The company has an installed capacity of approximately 18,800 MTPA for its products.
How did Shanti Inorganics perform in FY26?
Revenue increased by approximately 25% and profit after tax increased by around 28% compared with FY25.
How much revenue comes from exports?
Approximately 30% of the company’s revenue comes from exports, exposing it to international market and currency-related risks.
What is the Shanti Inorganics IPO price band?
The IPO price band is ₹79 to ₹83 per share.
What is the lot size?
The lot size is 1,600 shares.
What is the minimum investment?
Based on the provided IPO details, the minimum investment is ₹2,65,600, corresponding to two lots at the upper price band.
What is the GMP of Shanti Inorganics IPO?
The GMP provided is approximately 30.12%, or around ₹40,000 on the stated minimum application amount. GMP is unofficial and can change, so it should not be considered a guaranteed listing gain.
When will Shanti Inorganics IPO be listed?
The IPO is scheduled to open from 31 August to 2 September 2026, with allotment expected on 3 September and listing scheduled for 7 September 2026, subject to the final exchange and issue schedule.
Disclaimer
Investments in securities markets are subject to market risks. Read all related documents carefully before investing.
inXits is a SEBI-registered Investment Adviser (Registration No. INA000020369). This article is for educational purposes only and does not constitute personalised investment advice.
Registration granted by SEBI, membership of BSE and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.
Megha Joshi is a Research Analyst at inXits with 2.5 years of focused experience in equity markets. She conducts in-depth stock research and market analysis to support data-backed investment decision-making for clients.
